Spondylodiszitis

ZUSAMMENFASSUNG

Die hier vorliegende Arbeit zeigt den aktuellen Stand der Wissenschaft zur Thematik „Spondylodiszitis – Diagnostik und Therapie“, orientiert an der kürzlich erschienenen Leitlinie Spondylodiszitis (S2K) (Registernummer 151–001, Diagnostik und Therapie der Spondylodiszitis S2K, https://www.awmf.org/leitlinien/detail/ll/151-001.html) mit Fokus auf die Notfallsituation sowie das präklinische und klinische Management.

SUMMARY

This paper presents the current state of the art on the topic “Spondylodiscitis – Diagnosis and Therapy”, in particular based on the recently published German guideline Spondylodiscitis (S2K) (registration number 151–001, Diagnosis and Therapy of Spondylodiscitis S2K, https://www.awmf.org/leitlinien/detail/ll/151-001.html) focusing on the treatment strategy in emergency situations as well as on preclinical and clinical management.

Schlüsselwörter

Spondylodiszitis - Diagnostik - Therapie - Wirbelsäule

Keywords

Spondylodiscitis - diagnosis - therapy - spine

Publication History

Article published online:
10 December 2020

• Literatur

• 1 Herren C, Dreimann M, von der Höh NH. Diagnostik und Therapie der Spondylodiszitis – S2k-Leitlinie (AWMF-Registernummer: 151–001). 2020 Im Internet https://www.awmf.org/leitlinien/detail/ll/151-001.html DOI: Stand: 26. August 2020
• 2 Lener S, Hartmann S, Barbagallo GMV. et al Management of spinal infection: a review of the literature. Acta Neurochir (Wien) 2018; 160 (03) 487-496
• 3 Statistisches Bundesamt. Diagnosedaten der Krankenhäuser ab 2000 (Eckdaten der vollstationären Patienten und Patientinnen). Gliederungsmerkmale: Jahre, Behandlungs-/Wohnort; DOI: ICD10. In., 19.04.2017edn: 2017: Statistisches Bundesamt
• 4 Nickerson EK, Sinha R. Vertebral osteomyelitis in adults: an update. Br Med Bull 2016; 117 (01) 121-138
• 5 Jung N, Seifert H, Siewe J. et al Spondylodiszitis. Internist (Berl) 2013; 54 (08) 945-953
• 6 Guerado E, Cerván AM. Surgical treatment of spondylodiscitis. An update. Int Orthop 2012; 36 (02) 413-420
• 7 Herren C, Jung N, Pishnamaz M. et al Diagnosis and Treatment Options. Dtsch Arztebl Int 2017; 114 51–52 875-882
• 8 Zimmerli W. Clinical practice. Vertebral osteomyelitis. N Engl J Med 2010; 362 (11) 1022-1029
• 9 Underwood M, Buchbinder R. Red flags for back pain. BMJ 2013; 347: f7432
• 10 Lemaignen A, Ghout I, Dinh A. et al Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case-control study. Medicine (Baltimore) 2017; 96 (21) e6387
• 11 Casser H-R, Seddigh S, Rauschmann M. Acute Lumbar Back Pain. Dtsch Arztebl Int 2016; 113 (13) 223-234
• 12 Bernard L, Dinh A, Ghout I. et al Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet 2015; 385 9971 875-882
• 13 Bettini N, Girardo M, Dema E. et al Evaluation of conservative treatment of non specific spondylodiscitis. Eur Spine J 2009; 18 (Suppl. 01) 143-150
• 14 Giordan E, Marton E, Scotton G. et al Outcomes and risk factors for spontaneous spondylodiscitis: Case series and meta-analysis of the literature. J Clin Neurosci 2019; 68: 179-187
• 15 Shenoy K, Singla A, Krystal JD. et al Discitis in Adults. JBJS Rev 2018; 6 (06) e6
• 16 Brunkhorst FM, Weigand M, Pletz M. et al S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge (AWMF-Registernummer: 079 – 001). Im Internet https://www.awmf.org/uploads/tx_szleitlinien/079-001l_S3_Sepsis-Praevention-Diagnose-Therapie-Nachsorge_2020-03_01.pdf DOI: Stand: 31. Dezember 2018
• 17 Nolla JM, Ariza J, Gómez-Vaquero C. et al Spontaneous pyogenic vertebral osteomyelitis in nondrug users. Semin Arthritis Rheum 2002; 31 (04) 271-278
• 18 Sehn JK, Gilula LA. Percutaneous needle biopsy in diagnosis and identification of causative organisms in cases of suspected vertebral osteomyelitis. Eur J Radiol 2012; 81 (05) 940-946
• 19 Garg V, Kosmas C, Young PC. et al Computed tomography-guided percutaneous biopsy for vertebral osteomyelitis: a department’s experience. Neurosurg Focus 2014; 37 (02) E10
• 20 Rutges JPHJ, Kempen DH, van Dijk M. et al Outcome of conservative and surgical treatment of pyogenic spondylodiscitis: a systematic literature review. Eur Spine J 2016; 25 (04) 983-999
• 21 Lu M-L, Niu C-C, Tsai T-T. et al Transforaminal lumbar interbody debridement and fusion for the treatment of infective spondylodiscitis in the lumbar spine. Eur Spine J 2015; 24 (03) 555-560
• 22 Tschöke SK, Fuchs H, Schmidt O. et al Single-stage debridement and spinal fusion using PEEK cages through a posterior approach for eradication of lumbar pyogenic spondylodiscitis: a safe treatment strategy for a detrimental condition. Patient safety in surgery 2015; 9: 35
• 23 Hoeh NH von der, Voelker A, Hofmann A. et al Pyogenic Spondylodiscitis of the Thoracic Spine: Outcome of 1-Stage Posterior Versus 2-Stage Posterior and Anterior Spinal Reconstruction in Adults. World Neurosurg 2018; 120: e297-e303
• 24 Berbari EF, Kanj SS, Kowalski TJ. et al 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults. Clin Infect Dis 2015; 61 (06) e26-46
• 25 Park K-H, Cho O-H, Lee JH. et al Optimal Duration of Antibiotic Therapy in Patients With Hematogenous Vertebral Osteomyelitis at Low Risk and High Risk of Recurrence. Clin Infect Dis 2016; 62 (10) 1262-1269
• 26 Boucher HW. Partial Oral Therapy for Osteomyelitis and Endocarditis – Is It Time?. N Engl J Med 2019; 380 (05) 487-489
• 27 Li H-K, Rombach I, Zambellas R. et al Oral versus Intravenous Antibiotics for Bone and Joint Infection. N Engl J Med 2019; 380 (05) 425-436